INFIUSS HEALTH

INFIUSS HEALTH

Bringing global clinical Research and clinical trials direct-to-African participants. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
CAD273—409k (Dealroom.co estimates Sep 2022.)
San Jose California (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD202120222023
Revenues<1m<1m<1m
% growth-500 %-
  • Edit

Recent News about INFIUSS HEALTH

Edit
More about INFIUSS HEALTHinfo icon
Edit

Infiuss Health operates Africa's first remote clinical research platform, designed to streamline the process of finding and recruiting participants for clinical studies. The platform serves pharmaceutical companies, academic researchers, and healthcare organizations by providing access to a vast pool of vetted and eligible participants across Africa. Operating in the clinical research market, Infiuss Health aims to decentralize trials and make them more inclusive by leveraging a direct-to-patient approach. The business model revolves around offering subscription-based access to its platform, which includes tools for participant screening, recruitment, and data collection. By significantly reducing the time and cost associated with participant recruitment, Infiuss Health generates revenue through subscription fees and potentially through partnerships with research institutions and sponsors.

Keywords: remote clinical research, participant recruitment, Africa, decentralized trials, healthcare, pharmaceutical, academic research, data collection, subscription-based, vetted participants.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.